-
GSK to begin final-stage trials of respiratory syncytial virus vaccine
expresspharma
October 22, 2020
GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing, encouraged by mid-stage trial results.
-
First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people
expresspharma
October 22, 2020
Preliminary results from the late-stage human trial of Russia’s main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday.
-
Experts partner with UK government for COVID-19 human challenge trials
pharmatimes
October 22, 2020
The UK government has joined forces with experts from the NHS, academia and the private sector to explore and establish human challenge trials to aid the development of a COVID-19 vaccine.
-
Vaccine trials outside home market will help Chinese firms capture Asia, South and Central America markets: GlobalData
expresspharma
October 19, 2020
Pharma companies across the globe are working to develop a vaccine against COVID-19, which has already infected more than 38 million globally.
-
Vaccine delivery system should involve all levels of governments and citizen groups: PM Modi
expresspharma
October 19, 2020
He stressed that every step in the logistics, delivery, and administration should be put in place rigorously.
-
Confidence in reliability of data regarding COVID-19 therapies remains moderately high: Poll
pharmaceutical-technology
October 16, 2020
The need for a therapy to combat the contagious coronavirus disease (COVID-19) has led pharmaceutical companies to fast-track development plans, raising concerns over safety data.
-
Popular COVID-19 conspiracies linked to vaccine 'hesitancy'
worldpharmanews
October 16, 2020
A new study of beliefs and attitudes toward COVID-19 in five different countries - UK, US, Ireland, Mexico and Spain - has identified how much traction some prominent conspiracy theories have within these populations.
-
IIIT Delhi offers life-changing solutions against threats posed by COVID-19 vaccine
expresspharma
October 10, 2020
The department has also suggested that there is a need to utilise computer-aided techniques for the identification of potential vaccine candidates to fight against COVID-19.
-
Kindred Bio Expands Agreement with Vaxart
contractpharma
October 10, 2020
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.
-
Older people likely to be underrepresented in COVID-19 trials, says study
europeanpharmaceuticalreview
October 09, 2020
Researchers suggest, based on certain exclusions, older people are likely to be underrepresented in 50 percent of COVID-19 trials and all vaccine trials in the US.